QT Imaging (NASDAQ:QTI) Price Target Cut to $12.00 by Analysts at Ladenburg Thalmann & Co. Inc.

QT Imaging (NASDAQ:QTI) had its price target cut by Ladenburg Thalmann & Co. Inc. to $12.00 in a research note released on Wednesday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Other research analysts also recently issued research reports about the company. Weiss Ratings restated a “sell (e+)” rating on shares of QT Imaging in a research note on Tuesday, October 6th. Craig Hallum initiated coverage on QT Imaging in a research note on Monday, October 5th. They issued a “buy” rating and a $8.00 price objective for the company. Finally, D. Boral Capital assumed coverage on QT Imaging in a report on Friday, October 23rd. They issued a “buy” rating and a $9.00 price objective for the company. Four equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $9.67.

QT Imaging Stock Down 6.2%

Shares of QTI opened at $2.12 on Wednesday. The firm’s 50 day moving average price is $2.46 and its 200 day moving average price is $4.32. The company has a quick ratio of 2.06, a current ratio of 3.10 and a debt-to-equity ratio of 6.81. QT Imaging has a fifty-two week low of $1.96 and a fifty-two week high of $7.60.

QT Imaging (NASDAQ:QTI) last posted its earnings results on Tuesday, November 10th. The company reported ($0.02) earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.07. QT Imaging had a negative return on equity of 236.01% and a negative net margin of 54.63%. The firm had revenue of $7.34 million during the quarter, compared to analysts’ expectations of $10.79 million. As a group, analysts predict that QT Imaging will post -1.11 EPS for the current fiscal year.

Institutional Trading of QT Imaging

A number of hedge funds have recently added to or reduced their stakes in the stock. Stonepine Capital Management LLC purchased a new position in QT Imaging in the 2nd quarter valued at $407,000. Polar Asset Management Partners Inc. purchased a new position in QT Imaging during the 2nd quarter worth $210,000. Finally, BlackRock Inc. lifted its stake in shares of QT Imaging by 116.5% in the 2nd quarter. BlackRock Inc. now owns 61,353 shares of the company’s stock worth $250,000 after acquiring an additional 33,009 shares during the period. 24.19% of the stock is owned by institutional investors and hedge funds.

Key QT Imaging News

Here’s some of the latest news about QTI:

• Positive Sentiment: QT Imaging secured its first commercial order in the Gulf Cooperation Council region from American Hospital Dubai and plans a clinical research collaboration, offering a potential foothold for international growth. Article: QT Imaging Secures First GCC Commercial Order from American Hospital Dubai
• Positive Sentiment: Ladenburg Thalmann maintained a Buy rating while lowering its price target to $12, still indicating substantial potential upside from the cited $2.12 share price. Ladenburg Thalmann ratings
• Negative Sentiment: The company lowered its FY 2026 revenue outlook to $34 million, below the $39 million consensus estimate, citing shipment delays in the Middle East. Article: QT Imaging revises 2026 revenue outlook amid shipment delays

About QT Imaging

QT Imaging Holdings, Inc. (NASDAQ:QTI) is a medical technology company that develops advanced ultrasound-based imaging systems. Its technology is designed to create three-dimensional images of human tissue without using ionizing radiation. The company’s principal product is the QTscan, an automated breast-imaging system that uses sound waves to capture images without breast compression. The system is intended to support breast imaging and may be particularly relevant for evaluating breast tissue that can be difficult to assess with conventional mammography.